Abstract 4370283: Real-World Effectiveness of GLP-1 Receptor Agonists on Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
Multiple clinical trials have demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 Ras) improve symptoms, physical function, and potentially reduce hospitalizations in selected populations with HFpEF. However, the effectiveness of GLP-1 RAs in real-world populations with HFpEF is not well-characterized. Research Questions/Hypothesis: To evaluate the association between GLP-1 RA use and clinical outcomes in patients with…
